HIV infected people are living longer due to the success of combined antiretroviral therapy
(cART). However, greater than 40-70% of HIV infected individuals develop HIV associated …

Infectious diseases remain a pervasive threat to global and public health, especially in many
countries and rural urban areas. The main causes of such severe diseases are the lack of …

Compartmentalized HIV-1 replication within the central nervous system (CNS) likely
provides a foundation for neurocognitive impairment and a potentially important tissue …

Human immunodeficiency virus (HIV)-associated neurocognitive disorder (HAND) affects
roughly half the HIV-positive population. The symptoms of cognitive slowing, poor …

The character of central nervous system (CNS) HIV infection and its effects on neuronal
integrity vary with evolving systemic infection. Using a cross-sectional design and archived …

Neurological symptoms are frequently reported in patients suffering from COVID‐19.
Common CNS‐related symptoms include anosmia, caused by viral interaction with either …

Blood levels of the amino acid phenylalanine, as well as of the tryptophan breakdown
product kynurenine, are found to be elevated in human immunodeficiency virus type 1 (HIV …

HIV infection has changed from an acute devastating disease to a more chronic illness due
to combination anti-retroviral treatment (cART). In the cART era, the life expectancy of HIV …

Objective: HIV-associated neurocognitive disorders (HANDs) in the context of suppressive
combination antiretroviral therapy (cART) still occur. We explored the role of blood–brain …

Human immunodeficiency virus (HIV)-associated neurocognitive disorders (HAND) remain a
common end-organ manifestation of viral infection. Subclinical and mild symptoms lead to …